161 related articles for article (PubMed ID: 21191065)
41. Lung tumor-associated dendritic cell-derived resistin promoted cancer progression by increasing Wolf-Hirschhorn syndrome candidate 1/Twist pathway.
Kuo CH; Chen KF; Chou SH; Huang YF; Wu CY; Cheng DE; Chen YW; Yang CJ; Hung JY; Huang MS
Carcinogenesis; 2013 Nov; 34(11):2600-9. PubMed ID: 23955539
[TBL] [Abstract][Full Text] [Related]
42. Galectin-9 signaling prolongs survival in murine lung-cancer by inducing macrophages to differentiate into plasmacytoid dendritic cell-like macrophages.
Kadowaki T; Arikawa T; Shinonaga R; Oomizu S; Inagawa H; Soma G; Niki T; Hirashima M
Clin Immunol; 2012 Mar; 142(3):296-307. PubMed ID: 22177847
[TBL] [Abstract][Full Text] [Related]
43. TGF-β of lung cancer microenvironment upregulates B7H1 and GITRL expression in dendritic cells and is associated with regulatory T cell generation.
Ni XY; Sui HX; Liu Y; Ke SZ; Wang YN; Gao FG
Oncol Rep; 2012 Aug; 28(2):615-21. PubMed ID: 22614805
[TBL] [Abstract][Full Text] [Related]
44. Targeting galectin-1 overcomes breast cancer-associated immunosuppression and prevents metastatic disease.
Dalotto-Moreno T; Croci DO; Cerliani JP; Martinez-Allo VC; Dergan-Dylon S; Méndez-Huergo SP; Stupirski JC; Mazal D; Osinaga E; Toscano MA; Sundblad V; Rabinovich GA; Salatino M
Cancer Res; 2013 Feb; 73(3):1107-17. PubMed ID: 23204230
[TBL] [Abstract][Full Text] [Related]
45. The TLR7 agonist induces tumor regression both by promoting CD4⁺T cells proliferation and by reversing T regulatory cell-mediated suppression via dendritic cells.
Wang C; Zhou Q; Wang X; Wu X; Chen X; Li J; Zhu Z; Liu B; Su L
Oncotarget; 2015 Jan; 6(3):1779-89. PubMed ID: 25593198
[TBL] [Abstract][Full Text] [Related]
46. Galectin-1 co-clusters CD43/CD45 on dendritic cells and induces cell activation and migration through Syk and protein kinase C signaling.
Fulcher JA; Chang MH; Wang S; Almazan T; Hashimi ST; Eriksson AU; Wen X; Pang M; Baum LG; Singh RR; Lee B
J Biol Chem; 2009 Sep; 284(39):26860-70. PubMed ID: 19635795
[TBL] [Abstract][Full Text] [Related]
47. Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10.
Ilarregui JM; Croci DO; Bianco GA; Toscano MA; Salatino M; Vermeulen ME; Geffner JR; Rabinovich GA
Nat Immunol; 2009 Sep; 10(9):981-91. PubMed ID: 19668220
[TBL] [Abstract][Full Text] [Related]
48. Involvement of IL‑10 and granulocyte colony‑stimulating factor in the fate of monocytes controlled by galectin‑1.
Cheng DE; Chang WA; Hung JY; Huang MS; Kuo PL
Mol Med Rep; 2014 Nov; 10(5):2389-94. PubMed ID: 25231117
[TBL] [Abstract][Full Text] [Related]
49. Countering the advert effects of lung cancer on the anticancer potential of dendritic cell populations reinstates sensitivity to anti-PD-1 therapy.
Brassard J; Gill ME; Bernatchez E; Desjardins V; Roy J; Joubert P; Marsolais D; Blanchet MR
PLoS One; 2021; 16(11):e0260636. PubMed ID: 34847189
[TBL] [Abstract][Full Text] [Related]
50. Apoptosis and anergy of T cell induced by pancreatic stellate cells-derived galectin-1 in pancreatic cancer.
Tang D; Gao J; Wang S; Yuan Z; Ye N; Chong Y; Xu C; Jiang X; Li B; Yin W; Miao Y; Wang D; Jiang K
Tumour Biol; 2015 Jul; 36(7):5617-26. PubMed ID: 25725585
[TBL] [Abstract][Full Text] [Related]
51. Laricitrin ameliorates lung cancer-mediated dendritic cell suppression by inhibiting signal transducer and activator of transcription 3.
Chang WA; Hung JY; Jian SF; Lin YS; Wu CY; Hsu YL; Kuo PL
Oncotarget; 2016 Dec; 7(51):85220-85234. PubMed ID: 27833081
[TBL] [Abstract][Full Text] [Related]
52. ATP confers tumorigenic properties to dendritic cells by inducing amphiregulin secretion.
Bles N; Di Pietrantonio L; Boeynaems JM; Communi D
Blood; 2010 Oct; 116(17):3219-26. PubMed ID: 20651071
[TBL] [Abstract][Full Text] [Related]
53. Galectin-3 contributes to cisplatin-induced myeloid derived suppressor cells (MDSCs) recruitment in Lewis lung cancer-bearing mice.
Wang T; Chu Z; Lin H; Jiang J; Zhou X; Liang X
Mol Biol Rep; 2014 Jun; 41(6):4069-76. PubMed ID: 24615503
[TBL] [Abstract][Full Text] [Related]
54. Galectin-1 is required for the regulatory function of B cells.
Alhabbab R; Blair P; Smyth LA; Ratnasothy K; Peng Q; Moreau A; Lechler R; Elgueta R; Lombardi G
Sci Rep; 2018 Feb; 8(1):2725. PubMed ID: 29426942
[TBL] [Abstract][Full Text] [Related]
55. Tumor galectin-1 mediates tumor growth and metastasis through regulation of T-cell apoptosis.
Banh A; Zhang J; Cao H; Bouley DM; Kwok S; Kong C; Giaccia AJ; Koong AC; Le QT
Cancer Res; 2011 Jul; 71(13):4423-31. PubMed ID: 21546572
[TBL] [Abstract][Full Text] [Related]
56. Induced expression of B7-H3 on the lung cancer cells and macrophages suppresses T-cell mediating anti-tumor immune response.
Chen C; Shen Y; Qu QX; Chen XQ; Zhang XG; Huang JA
Exp Cell Res; 2013 Jan; 319(1):96-102. PubMed ID: 22999863
[TBL] [Abstract][Full Text] [Related]
57. The impact of intraoperative vaccination with IL-12 modified autologous tumor cells in the Lewis lung carcinoma mouse model.
Dietrich A; Stockmar C; Endesfelder S; Guetz A; Aust G
J Cancer Res Clin Oncol; 2012 Jun; 138(6):901-6. PubMed ID: 22322363
[TBL] [Abstract][Full Text] [Related]
58. Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment.
Ito K; Stannard K; Gabutero E; Clark AM; Neo SY; Onturk S; Blanchard H; Ralph SJ
Cancer Metastasis Rev; 2012 Dec; 31(3-4):763-78. PubMed ID: 22706847
[TBL] [Abstract][Full Text] [Related]
59. Deguelin Induces the Apoptosis of Lung Squamous Cell Carcinoma Cells through Regulating the Expression of Galectin-1.
Yan B; Zhao D; Yao Y; Bao Z; Lu G; Zhou J
Int J Biol Sci; 2016; 12(7):850-60. PubMed ID: 27313498
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of tumourigenicity of small cell lung cancer cells by suppressing Id3 expression.
Kamalian L; Forootan SS; Bao ZZ; Zhang Y; Gosney JR; Foster CS; Ke Y
Int J Oncol; 2010 Sep; 37(3):595-603. PubMed ID: 20664928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
